Showing 1081-1090 of 20387 results for "".
How Ichthyosis Can Affect Mental Health—And How We Can Address It
https://reachmd.com/programs/practical-dermatology/how-ichthyosis-can-affect-mental-health-and-how-we-can-address-it/24029/As a rare condition, ichthyosis can bring additional burdens upon patients and caregivers alike.IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
https://reachmd.com/programs/cme/ibd-care-reimagined-personalized-proactive-and-target-driven-management/54174/Explore IBD treatment selection in this comprehensive program for community gastroenterologists, with topics including therapies, targets, and emerging data.Collaborative Care for CRSwNP Expert and Patient Insights
https://reachmd.com/programs/cme/collaborative-care-for-crswnp-expert-and-patient-insights/36695/Chronic rhinosinusitis with nasal polyps (CRSwNP) presents a large burden on more than 3 million patients with the conditions — especially when intertwined with asthma and allergy. Join our discussion between patients with CRSwNP and leading experts in ENT, allergy, and pulmonary medicine as they:Calming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
https://reachmd.com/programs/cme/calming-overactive-immune-response-and-reducing-inflammation-with-tyk2-inhibition-in-psoriasis/50978/Join us to learn about the emerging data with TKY2 inhibitors for treatment of psoriasis.Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 4
https://reachmd.com/programs/practical-dermatology/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-4/56872/In the fourth installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, focus on how adjuvant skincare may influence treatment pathways, including delaying or optimizing escalation to systemic therapies.1 Draelos Z, HoSurvey Says: Aligning Early Advanced IBD Therapy with Patient Priorities
https://reachmd.com/programs/cme/survey-says-aligning-early-advanced-ibd-therapy-with-patient-priorities/57916/On-demand webcast on the latest advances in managing inflammatory bowel disease (IBD) and expert-informed strategies for providing guideline-concordant care to patients with IBD.Identifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
https://reachmd.com/programs/medical-industry-feature/adult-chronic-immune-thrombocytopenia-management/56537/Chronic immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts and increased bleeding risk, and can have significant impacts on patients’ quality of life.1 Treatment decisions require a personalized approach that considers both clinical factors and patient prefeInnovations in Precision Medicine: Leveraging Guideline-Based Immunotherapy and Targeted Treatments in Gynecologic Oncology
https://reachmd.com/programs/cme/Innovations-in-Precision-Medicine-Leveraging-Guideline-Based-Immunotherapy-and-Targeted-Treatments-in-Gynecologic-Oncology/37235/Multidisciplinary experts explore biomarker-driven strategies, immunotherapy, and personalized care in cervical and endometrial cancer management.Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis
https://reachmd.com/programs/cme/implementing-the-latest-diagnostic-and-treatment-approaches-for-generalized-myasthenia-gravis/32961/Examine FcRn inhibitors in gMG with expert discussion on mechanisms, clinical trial results, therapeutic use, and individualized treatment approaches.DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
https://reachmd.com/clinical-practice/oncology-hematology/destiny-breast11-trastuzumab-deruxtecan-followed-by-thp-yields-new-indication-in-the-neoadjuvant-setting/57280/DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.